Austin Ostermeier

Keyphrases

1. Action Potential 30%
2. Antibiotics 29%
3. Ascl1 30%
4. BRN2 30%
5. Ceftriaxone 92%
6. Critically Ill children 92%
7. Defined Factors 46%
8. Desmoplastic Small Round Cell Tumor (DSRCT) 46%
9. Direct Conversion 46%
10. Efficiency Improvement 46%
11. FDG Positron Emission Tomography/computed Tomography 46%
12. Fetal Exposure 46%
13. Fibroblasts 46%
14. Free Concentration 23%
15. Functional Neurons 61%
16. Hepatocellular Carcinoma 46%
17. Hepatocellular Carcinoma Progression 18%
18. Human Fibroblasts 30%
19. Human Neuronal Cells 46%
20. Induced Neuronal Cells 76%
21. Lineage-determining Transcription Factor 30%
22. Minor Procedures 46%
23. Monte Carlo Simulation 46%
24. Mouse Embryonic Fibroblasts 30%
25. MYT1L 30%
26. Neural Lineage 30%
27. Non-neural 30%
28. Notch Signaling 46%
29. Older Adults 100%
30. Pediatric Hospitalist 46%
31. Pediatric Intensive Care Unit 24%
32. Pharmacokinetic Parameters 53%
33. PLP1 23%
34. Population Pharmacokinetics 46%
35. Positron Emission Tomography-computed Tomography (PET-CT) 46%
36. Primary Care Providers 46%
37. Provider Communication 46%
38. Regenerative Medicine 30%
39. Regulatory T (Treg) Cells 46%
40. Resident Autonomy 46%
41. Retinoblastoma Pathway 46%
42. Self-perceived Competence 46%
43. Senior Residents 46%
44. Sepsis 69%
45. Simulation Support 46%
46. Somatic Cells 30%
47. Target Attainment 92%
48. Transcription Factor 76%
49. Treg 46%
50. Twice-daily Dosing 46%